Skip to main content

Advertisement

Figure 3 | Malaria Journal

Figure 3

From: Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

Figure 3

Distribution of parasite clearance times (hours) within the EC50 and k max deciles derived from the 5000 parameter sets for the anti-malarial combination therapy, artesunate (ARS) and mefloquine (MQ). Top panels are for artesunate (EC50 – left hand side, kmax right hand side) and bottom panels are for mefloquine (EC50 – left hand side, kmax right hand side).

Back to article page